Russell Investments Group, Ltd. Tg Therapeutics, Inc. Transaction History
Russell Investments Group, Ltd.
- $69.8 Billion
- Q4 2024
A detailed history of Russell Investments Group, Ltd. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 34,706 shares of TGTX stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,706
Previous 8,200
323.24%
Holding current value
$1.38 Million
Previous $191,000
446.6%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding TGTX
# of Institutions
373Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$454 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$367 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$127 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$111 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.79B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...